RSS

biotechnology

Biotechnology company, Leukocare, and pharma company, Boehringer Ingelheim, have entered into a licence agreement in the field of veterinary diagnostics. more

News

Biotechnology company, Shire, has announced a professional training development collaboration with the National Institute of Bioprocessing Research and Training (NIBRT) in Dublin, Ireland. more

News

Commercial stage biotechnology acceleration development company, Q BioMed, and Bio-Nucleonics, licensor of Strontium-89 Chloride, have filed for regulatory approval of a new manufacturing facility by the US Food and Drug Administration (FDA). more

Technology

Clinical stage biotechnology company, Destiny Pharma, has announced that the US Food and Drug Administration (FDA) has accepted its investigational new drug application (IND) for its lead clinical drug candidate, XF-73. more

News

This case study details Schubert-Pharma’s automated solution for a small-component packaging task. more

Opinion

Biotechnology company, GamaMabs Pharma, has received orphan drug designation from the US Food and Drug Administration (FDA) for its lead compound GM102 to treat advanced ovarian cancers. more

News

UK-based biotechnology company, Stabilitech Biopharma, has received further funding from Innovate UK to develop its oral Zika virus vaccine so that it is first-in-human ready by 2020. more

News

Biotechnology company, Clover Biopharmaceuticals, has announced its choice of biomanufacturing platform as being GE Healthcare’s FlexFactory for its new facility located in Changxing, China. more

News

Pandion Therapeutics, a biotechnology company, has raised $58 million at the completion of its Series A financing round, which will be used to advance its initial drug programmes for autoimmune and inflammatory diseases more

News

A new strategy to tackle the issue of long-term treatment efficacy in cancer patients has been developed by researchers from the Netherlands Cancer Institute in collaboration with international biotechnology company, Genmab. more

News

Biotechnology company, Pherecydes Pharma, has raised €8.7 million in a Series B round of funding, which it plans to use to support the production of phages for compassionate use in accordance with good manufacturing practuces (GMP). more

News

Innovative molecular diagnostics company, Biocartis Group, and biotechnology company, Amgen, have signed a new companion diagnostic (CDx) development agreement for a novel oncology compound. more

News

A research collaboration for the development of a specific modified peptide targeting rheumatoid arthritis (RA) has been formed between Pfizer and Imcyse — a biotech company developing specific therapies for the treatment of severe chronic diseases. more

News

An immune-oncology focused biotechnology company, BriaCell, has provided a clinical update on its lead immunotherapy drug for advanced breast cancer. more

News

Biotechnology company, VirionHealth, has won non-dilutive funding from the US Defense Advanced Research Projects Agency (DARPA) to support development of its new class of biological antivirals. more

News

Global biotechnology company, Shire, has filed its first submission to the US Food and Drug Administration (FDA) for a new plasma manufacturing facility in Covington, Georgia, to support growth in its immunology franchise. more

News

Genoscience Pharma has announced that initiation of a Phase Ib/IIa study of its most advanced compound, GNS561, for the treatment of patients with advanced hepatocarcinoma (HCC), has received approval from the US Food and Drug Administration (FDA). more

News

Lonza and Massachusetts Eye and Ear (MEE) have granted Akouos (a new biotechnology company) licences for exclusive rights to the ancestral adeno-associated viral vectors (Anc-AAV) gene therapy platform for all hearing and balance disorders. more

News

Phillips-Medisize has entered into an agreement with biotechnology company Dance Biopharm to develop a connected insulin inhaler. more

Technology

Molecular diagnostics company, Biocartis, has signed a companion diagnostic (CDx) development agreement with biotechnology company, Amgen, for the Idylla RAS biomarker tests. more

News